Wilmot Cancer Institute
Rochester, New York, 14642, United States
NCT Number: NCT04243512
The investigators will assess the feasibility of delivering a time-restricted eating (TRE) intervention among cancer survivors with fatigue.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14642, United States
In this study, the feasibility of delivering a time-restricted eating (TRE) intervention among fatigued cancer survivors will be assessed. The participants will be asked to eat ad libitum only within a self-selected 10-h window each day for 14 days. The primary aim is to assess the adherence of the participants to the 10-h TRE intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Participants must...)
Exclusion criteria
(Participants must not...):
Restrict food and beverage intake (except water) to a 10-hour window
Time frame: 14 days
Adherence will be assessed as the percent of days that each participant adheres to the 10-h TRE dietary pattern
University of Rochester
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06605729
Behavior, Cancer Survivorship
Wilrijk, Antwerp, Belgium
View Trial DetailsNCT06191666
Body Weight, Cancer Survivorship
Aurora, Colorado, United States
View Trial DetailsNCT06171945
Behavior, Body Weight
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05648604
Basal Cell Carcinoma, Behavior
Tucson, Arizona, United States
View Trial Details